Avid Bioservices Income Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	31.67	27.41	25.29	18.37	16.75
Other Revenue	1.25	0.36	2.27	0.15	-
Revenue	32.92	27.77	27.56	18.52	16.75
Revenue Growth (YoY)	18.55%	0.77%	48.81%	10.55%	-
Cost of Revenue	18.98	19.23	18.71	12.59	9.9
Gross Profit	13.94	8.54	8.85	5.92	6.85
Selling, General & Admin	1.34	1.45	1.47	0.85	0.47
Other Operating Expenses	1.69	-2.87	-1.96	-1.76	-0.37
Operating Expenses	9.36	3.76	5.06	2.72	3.62
Operating Income	4.58	4.78	3.8	3.2	3.23
Interest Expense	-1.57	-1.23	-0.41	-0.2	-0.25
Interest & Investment Income	0.28	-	-	-	-
Currency Exchange Gain (Loss)	-0	0	-0	-	-0
Other Non Operating Income (Expenses)	0.13	0.13	0.02	0	0
EBT Excluding Unusual Items	3.42	3.68	3.41	3	2.98
Gain (Loss) on Sale of Investments	-0	-0.02	-0.01	-0.43	-
Pretax Income	3.42	3.66	3.4	2.57	2.98
Income Tax Expense	1.6	1.28	-0.34	0.07	0.92
Earnings From Continuing Operations	1.82	2.38	3.75	2.5	2.06
Minority Interest in Earnings	-0.03	-0.01	-0	-0.39	-0.33
Net Income	1.8	2.37	3.74	2.11	1.73
Net Income to Common	1.8	2.37	3.74	2.11	1.73
Net Income Growth	-24.35%	-36.57%	77.47%	21.81%	-
Shares Outstanding (Basic)	19	3	3	2	-
Shares Outstanding (Diluted)	19	3	3	2	-
Shares Change (YoY)	598.30%	-	12.20%	-	-
EPS (Basic)	0.10	0.89	1.40	0.88	-
EPS (Diluted)	0.10	0.89	1.40	0.88	-
EPS Growth	-89.17%	-36.57%	58.17%	-	-
Free Cash Flow	3.39	0.62	-3.85	4.84	3.29
Free Cash Flow Per Share	0.18	0.23	-1.44	2.03	-
Dividend Per Share	0.014	0.008	-	-	-
Dividend Growth	70.00%	-	-	-	-
Gross Margin	42.34%	30.75%	32.12%	31.99%	40.90%
Operating Margin	13.92%	17.22%	13.77%	17.29%	19.28%
Profit Margin	5.45%	8.55%	13.58%	11.39%	10.33%
Free Cash Flow Margin	10.31%	2.23%	-13.98%	26.12%	19.66%
EBITDA	9.21	9.58	8.25	6.64	6.73
EBITDA Margin	27.98%	34.49%	29.92%	35.83%	40.17%
D&A For EBITDA	4.63	4.8	4.45	3.43	3.5
EBIT	4.58	4.78	3.8	3.2	3.23
EBIT Margin	13.92%	17.22%	13.77%	17.29%	19.28%
Effective Tax Rate	46.70%	34.88%	-	2.58%	31.00%
Revenue as Reported	44.65	39.41	35.27	24.14	17.49

Source: S&P Global Market Intelligence. Standard template. Financial Sources.